Scrip    Clinica    RAJ    Scrip Clinical Research    AnimalPharm   
Email ID
Password
Forgotten your password?
Sign me in automatically next time
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
Deals
|
M&A
|
Financials
|
Strategy
|
Lifecycle Management
|
Legal
|
Business - Lifecycle Management
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK Promote your vacancy here
Extended review for Acetadote supplement hits Cumberland shares
25 August 2010
Shares in Cumberland Pharmaceuticals, which have languished since the company broke the deadlock in a recession-hit pharmaceutical sector by raising around $75 million net in an IPO last August, took a further battering yesterday after Cumberland ...
FDA partially grants petitions on bioequivalence guidance for generic Pentasa and Asacol
25 August 2010
The US FDA opposes the idea that applicants of generic or "follow-on" formulations of extended or delayed-release oral mesalamine drug products need to show bioequivalence to ulcerative colitis treatments Pentasa or Asacol through data from ...
FDA panels vote against Jazz bid to sell sodium oxybate for fibromyalgia
23 August 2010
A joint meeting on 20 August of two US FDA advisory committees put major roadblocks in the way of Jazz Pharmaceuticals' new drug application (NDA) to sell sodium oxybate as a treatment for fibromyalgia. The panel of outside experts on arthritis ...
NextWave and Tris enter CNS collaboration
16 August 2010
NextWave Pharmaceuticals, a US company developing niche products to address unmet needs in conditions such as attention-deficit hyperactivity disorder (ADHD), has expanded its relationship with drug delivery specialist Tris Pharma to focus on ...
Endo to acquire Opana partner Penwest for $5 a share
10 August 2010
Endo Pharmaceuticals has moved to optimise its Opana pain management franchise and open up new drug delivery and formulation possibilities across its pipeline with an agreement to acquire drug development partner Penwest Pharmaceuticals for $5.00 ...
 
2010 Scrip 100 - Mixed fortunes on the R&D front
23 August 2010
Continued problems with anti-obesity drugs, more measures designed to improve R&D efficiency, and the approval of first-in-class therapeutics such as Amgen's Prolia and Dendreon's Provenge: the first ...
Liver cancer becomes more preventable and treatable
12 August 2010
New drugs to treat viral hepatitis infection, coupled with renewed interest from companies in developing therapies to treat liver cancer following Nexavar's approval, have improved prospects for both ...
Are we near a telehealth tipping point?
30 June 2010
Telehealth is the use of IT to diagnose, treat and/or monitor a patient in a different physical location from the expert providing the care. At present, it is only targeted towards a segment of acute ...
 
GW high on pipeline of cannabis extracts
23 August 2010
GW Pharma has enjoyed recent success with its cannabinoid extract product Sativex (nabiximols), which is now approved in the UK and Spain as an add-on therapy for spasticity in multiple sclerosis, ...
Connexios: Harnessing the Indian cost advantage in network biology
01 June 2010
Imagine if a start-up company could afford to hire enough high-calibre scientists to spend years creating a detailed map of a broad and complex pathology like metabolic disease, incorporating large ...
Face to face: Ex-Novartis manager takes two-step approach to women's health at Lumavita
12 January 2010
Many pharmaceutical and biotech companies devote themselves to the discovery and development of novel drugs for unmet medical needs. However, with R&D costs and regulatory hurdles multiplying, and ...
 
GLP-1 receptor agonists vie for diabetes market share
13 July 2010
After enjoying almost five years of exclusivity, Lilly/Amylin's first-in-class antidiabetic GLP-1 receptor analogue Byetta (exenatide) has started to feel competition nipping at its heels. Asher ...
AstraZeneca judgement changes the rules for dominant companies
07 July 2010
On 1 July 2010 the EU General Court handed down its judgement in the long-running saga of AstraZeneca's proton pump inhibitor anti-ulcer product Losec (omeprazole). Although dealing with events that ...
Commentary: Experts alert to dangers of panic over flu pandemic
14 August 2009
Last month's launch of the National Pandemic Flu Service in the UK was hailed by some as an innovative way of easing the burden of the imminent pandemic on the country's already over-worked National ...
 
Protective efficacy of different strategies employing Mycobacterium leprae heat-shock protein 65 against tuberculosis
01 September 2008
Background: Tuberculosis is a major threat to human health. The high disease burden remains unaffected and the appearance of extremely drug-resistant strains in different parts of the world argues in ...
Morphine sulfate extended-release capsules for the treatment of chronic, moderate-to-severe pain
01 June 2008
Background: Morphine sulfate extended-release capsules (KADIAN ® ) contain polymer-coated morphine sulfate pellets that are formulated to deliver sustained plasma morphine levels with minimal ...
Lisdexamfetamine dimesylate: the first long-acting prodrug stimulant treatment for attention deficit/hyperactivity disorder
01 June 2008
Background: Lisdexamfetamine dimesylate is the first long-acting prodrug stimulant and is indicated for the treatment of attention deficit/hyperactivity disorder. Lisdexamfetamine dimesylate is a ...
 
COMPANY/ORGANISATION
CONDITION
GEOGRAPHY
DRUG
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
Terms & Conditions
Privacy Policy
Sitemap
About Us
Advertise
Subscribe
Scrip
Clinica
RAJ
Scrip Clinical Research
Animal Pharm